This article explores practical ways to reduce pharmaceutical intermediate costs through smarter supply chain management, optimized synthesis routes, process intensification, and green chemistry.
Tianming Pharmaceutical Group will participate in the 93rd China International Pharmaceutical Ingredients and Intermediates Exhibition (CPhI China 2025) from November 12–14 at the Chongqing International Expo Center, Booth N5M07.
This guide explores its molecular mechanism, clinical performance, dosage strategy, side effects, and synthesis challenges from a chemist’s real-world perspective.
This article explores five critical elements that define successful quality systems.Tianming Pharmaceutical Group, quality is treated not as a cost but as an investment, ensuring every intermediate meets global GMP standards for consistency, purity, and performance.
This guide explains how to assess supplier quality systems, manufacturing technology, and reliability — helping pharmaceutical companies secure a trusted partner for long-term success.
Explore chiral intermediates in drug development, their synthesis, industrial challenges, and AI-driven innovations shaping modern pharmaceuticals.
The active pharmaceutical ingredient (API) manufacturing process is the foundation of modern drug development. This article provides an in-depth overview of the API manufacturing process and highlights why it is central to the pharmaceutical industry.
By understanding their strengths and differences, consumers can identify which ingredient best fits their personal health goals
Custom API synthesis is transforming modern drug development by offering flexible, scalable, and GMP-compliant solutions. Partner with us to accelerate innovation and bring breakthrough medicines to market faster.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
